Bonnie L. Bassler - Jul 1, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Stock symbol
REGN
Transactions as of
Jul 1, 2021
Transactions value $
-$468,319
Form type
4
Date filed
7/2/2021, 04:01 PM
Previous filing
Jun 30, 2021
Next filing
Aug 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1M +2.56K +287.09% $391.92 3.45K Jul 1, 2021 Direct F1
transaction REGN Common Stock Sale -$1.47M -2.56K -74.17% $575.00 891 Jul 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.56K -24.99% $0.00 7.68K Jul 1, 2021 Common Stock 2.56K $391.92 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.